Synbio Tech (ROCO:1295) Payments of Debt: NT$-233 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1295 Synbio Tech Inc ROCO:1295
43 GF Score
Price NT$46.40
! 9 Warning Signs
View Full Analysis

What is Synbio Tech Payments of Debt?

Synbio Tech ROCO:1295 -0.43% 43 Payments of Debt is NT$-233 Mil as of Mar. 2026. GuruFocus rates ROCO:1295 with a GF Score™ of 43/100. The stock has 9 warning signs investors should review.

Synbio Tech's Payments of Debt for the three months ended in Mar. 2026 was NT$-67 Mil.

Synbio Tech's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was NT$-233 Mil.

Synbio Tech Payments of Debt Related Terms

Synbio Tech Payments of Debt Historical Data

* Premium members only.

The historical data trend for Synbio Tech's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synbio Tech Payments of Debt Chart

Synbio Tech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial -57.45 -133.25 -186.90 -25.88 -205.15

Synbio Tech Quarterly Data
Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.91 -50.95 -54.78 -60.52 -67.15
ROCO:1295
43GF Score
Synbio Tech Inc ROCO:1295
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synbio Tech Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-233 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of NT$-233 Mil mean?
Synbio Tech (ROCO:1295) has a Payments of Debt of NT$-233 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Synbio Tech and its competitors.
Is Synbio Tech's Payments of Debt too high?
Synbio Tech's current Payments of Debt is NT$-233 Mil. Overall, Synbio Tech has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Payments of Debt compare to VRTX and REGN?
Synbio Tech's Payments of Debt of NT$-233 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Synbio Tech and its competitors. Synbio Tech's current Payments of Debt is NT$-233 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current Payments of Debt of NT$-233 Mil. The current Payments of Debt is NT$-233 Mil. Synbio Tech's overall GF Score™ is 43/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Payments of Debt is NT$-233 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Synbio Tech Business Description

Address No.82, Beiling 6th Road, Luzhu District, Kaohsiung, TWN, 821
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
43GF Score

Get the complete analysis for ROCO:1295

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$46.40
Price